Extendicare Inc's stock has seen significant movement this week amid market conditions and company updates.
Extendicare Inc (EXE.TO) has experienced a decline in its stock price this week, closing down 2.43% on Wednesday and 8.11% over the past week. The health care company continues to capture investor interest amid a backdrop of strong year-to-date performance, up 50.43%. Recent earnings call highlights may have influenced this week's price action, providing insights into the company's operational performance.
Advertisement
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeAdvertisement
Market cap
$3.09B
P/E
23.9x
Div. yield
1.58%
Div. / share
$0.51
52W high
$39.09
52W low
$12.39
1W change
-8.11%
Beta
1.16
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 24.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$39.61
+24.9% Upside
Current Price
C$31.71
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
32.8%
Annualized
90-Day Vol
35.3%
Annualized
Trend (90d)
-18.4%
Annualized drift
90d Mean
C$29.69
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$31.02 | C$27.71 – C$34.74 |
| 60 trading days | C$30.35 | C$25.87 – C$35.61 |
| 90 trading days | C$29.69 | C$24.41 – C$36.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the implications of Extendicare's recent earnings call and the company's strong year-to-date performance against the current stock price trajectory. The technical indicators suggest a potential area for cautious observation as the stock approaches its 200-day moving average.
C$32.08 Closing Price with 8.11% Weekly Decline
Extendicare's stock has retraced significantly from its recent highs, now trading at C$32.08, within 74% of its 52-week range of C$12.39 to C$39.09.
Bull case
Analysts have set an average target of C$39.61 for Extendicare, suggesting a potential upside of 23.5% from the current price. The company's strong year-to-date performance and impressive return on equity (ROE) of 43.8% indicate solid operational efficiency.
Bear case
However, the stock has shown a downward trend recently, with a significant drop from its 50-day moving average of C$35.12. The trading volume has increased, nearly doubling the 20-day average, which may indicate heightened volatility and investor concern.
Price Action Overview
Extendicare Inc's stock closed at C$32.08 on Wednesday, reflecting a decrease of 2.43% for the day and a notable 8.11% decline over the past week. Despite these recent dips, the stock has performed strongly year-to-date, gaining 50.43%. Investors are closely monitoring the stock's movement as it approaches crucial technical levels.
Advertisement
Company News and Earnings Insights
The recent Q2 earnings call held on August 9, 2026, provided key insights into Extendicare's operations and financial health. Highlights from the call indicated a focus on improving service delivery and maintaining profitability in the competitive health care sector. These insights may have influenced market sentiment, contributing to the recent volatility in the stock price.
Technical Picture
From a technical perspective, Extendicare is currently trading below its 50-day moving average of C$35.12, indicating a bearish trend. The stock is above its 200-day moving average of C$27.21, suggesting long-term support. With a beta of 1.16, the stock exhibits slightly higher volatility compared to the market. The 52-week range of C$12.39 to C$39.09 shows that the stock is currently trading at 74% of its range, which may signal potential price action in the near term.
Volume Analysis
The trading volume for Extendicare has surged to 792,890 shares, significantly above the 20-day average volume of 510,661 shares. This increased volume, at 1.92 times the average, may indicate heightened investor activity and interest, which could lead to further price fluctuations in the coming sessions.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
